A novel study has analyzed the cost-effectiveness of different Down syndrome (DS) screening strategies. The result confirms that noninvasive prenatal testing (NIPT) outperforms second-trimester serum ...
The NIPT market's growth opportunities lie in expanding its clinical applications, leveraging advanced sequencing technologies, and increasing adoption for low-risk pregnancies. Rising maternal age, ...
Non-invasive prenatal screening techniques can detect chromosomal abnormalities including Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13). These ...
A breakthrough in prenatal care, Unity Confirm enables non-invasive confirmation for high-risk screening results through the capture of intact circulating fetal cells using BillionToOne's Fetal Cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results